Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate 
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers 
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
Boeing Signals Progress on Delayed 777X Program With Planned April First Flight 
Tesla Launches New Model Y Variant in the US Starting at $41,990 
Instagram Outage Disrupts Thousands of U.S. Users 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition 
PLEASANTON, Calif., Aug. 09, 2017 -- The Cooper Companies, Inc. (NYSE:COO) today announced that it will present at two upcoming financial conferences. Albert G. White III, Executive Vice President, Chief Financial Officer & Chief Strategy Officer, will represent the Company.
- The Baird 2017 Healthcare Conference in New York, NY on September 6, 2017 at 12:15 PM ET.
- The Wells Fargo Securities 2017 Healthcare Conference in Boston, MA on September 7, 2017 at 8:50 AM ET.
A live audio webcast of each presentation will be available on the Investor Relations section of the Company's website at www.coopercos.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT: Kim Duncan Vice President, Investor Relations The Cooper Companies, Inc. [email protected]
